This Yelp Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday
This Yelp Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday
這位Yelp分析師以看淡的態度開始覆蓋報道；以下是週一的前5個啓動項目。
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
華爾街頂級分析師改變了對這些頂級公司的展望。如需查看包括升級和降級在內的所有分析師評級變化的完整視圖，請參閱我們的分析師評級頁面。
- Benchmark analyst Cody Acree initiated coverage on Arm Holdings plc (NASDAQ:ARM) with a Hold rating. ARM Holdings shares gained 5.9% to close at $147.37 on Friday. See how other analysts view this stock.
- EF Hutton analyst Jason Kolbert initiated coverage on Immunic, Inc. (NASDAQ:IMUX) with a Buy rating and announced a price target of $17. Immunic shares gained 2% to close at $1.52 on Friday. See how other analysts view this stock.
- Jefferies analyst Amy Li initiated coverage on Biohaven Ltd. (NYSE:BHVN) with a Buy rating and announced a price target of $57. Biohaven shares gained 6.5% to close at $38.08 on Friday. See how other analysts view this stock.
- B of A Securities analyst Nitin Bansal initiated coverage on Yelp Inc. (NYSE:YELP) with an Underperform rating and announced a price target of $30. Yelp shares gained 2.2% to close at $34.44 on Friday. See how other analysts view this stock.
- HC Wainwright & Co. analyst Raghuram Selvaraju initiated coverage on Coya Therapeutics, Inc. (NASDAQ:COYA) with a Buy rating and announced a price target of $18. Coya Therapeutics shares rose 7.4% to close at $6.40 on Friday. See how other analysts view this stock.
- Benchmark的分析師Cody Acree對納斯達克（NASDAQ）的Arm Holdings plc進行了持有評級的覆蓋。週五，Arm Holdings股票上漲5.9%，收於147.37美元。接下來我們看看其他分析師對該股票的看法。
- EF Hutton的分析師Jason Kolbert對納斯達克（NASDAQ）的Immunic，Inc進行了買入評級的覆蓋，並宣佈了17美元的目標價。週五，Immunic股票上漲2%，收於1.52美元。接下來我們看看其他分析師對該股票的看法。
- Jefferies的分析師Amy Li對紐約證券交易所（NYSE）的Biohaven Ltd.進行了買入評級的覆蓋，並宣佈了57美元的目標價。週五，Biohaven股票上漲6.5%，收於38.08美元。接下來我們看看其他分析師對該股票的看法。
- b of A Securities的分析師Nitin Bansal對紐約證券交易所（NYSE）的Yelp Inc.進行了弱於大盤評級的覆蓋，並宣佈了30美元的目標價。週五，Yelp股票上漲2.2%，收於34.44美元。接下來我們看看其他分析師對該股票的看法。
- HC Wainwright & Co.的分析師Raghuram Selvaraju對納斯達克（NASDAQ）的Coya Therapeutics，Inc進行了買入評級的覆蓋，並宣佈了18美元的目標價。週五，Coya Therapeutics股票上漲7.4%，收於6.40美元。接下來我們看看其他分析師對該股票的看法。
Considering buying YELP stock? Here's what analysts think:
考慮購買YELP股票嗎？以下是分析師的看法：
- Jim Cramer: 'Hold On' To Builders FirstSource, 'Here's The Problem' With Viking Therapeutics
- 吉姆·克雷默： 持有builders firstsource股票，viking therapeutics存在問題。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。